Yavuz Akif Selim

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Dear Editor, Philadelphia-negative myeloproliferative neoplasms (MPNs) were first described 65 years ago. Yet, the molecular features of the disease have become of interest since 2005 following the identification of the JAK2V617F mutation. 1 Between 90% and 98% of patients with polycythemia vera and about 50% of patients with essential thrombocythemia (ET)(More)
  • 1